Home > Result Summaries: Compounds > naratriptan > Result Summary for S2WA1010

Result Summary for S2WA1010

Result Summary

Protocol ID:	S2WA1010
Clinical Study ID:	S2WA1010 (534/040)
Official Title:	A study to investigate the interaction of naratriptan and dihydroergotamine in healthy volunteers.
Phase:	Phase 1
Study Indications or Diseases:	Migraine Disorders
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Abstract; no additional information beyond what was provided in the label. Kempsford RD, Cephalalgia 1997;17(3):416. Abstract: A study to investigate the potential interaction of naratriptan and dihydroergotamine. Kempsford, RD MD, Nicholls, B MD, Lam, R MD, and Wintermute, S Md 39th Annual Scientific Meeting of the American Association for the Study of Headache 6/22/1997 New York, New York Abstract: A study to investigate the potential interaction of naratriptan and dihydroergotamine. Kempsford, R D, Nicholls, B, Lam, R, and Wintermute, S 8th Congress of the International Headache Society 6/10/1997 Amsterdam, Netherlands